Diabetic rats treated by low molecular weight heparin OP 2123/parnaparin: Morphological changes in the kidney and heart

Journal of Diabetes and its Complications

Volumn 18, Issue 2, 2004, Pages 119-125

  Artico, M ^a   De Santis, S ^a   Tranquilli Leali, F M ^a   Cavallotti, D ^a   Celestini, A ^a   Cavallotti, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Diabetes; Heart; Kidney; Low molecular weight heparin (OP 2123 parnaparin)

Indexed keywords

ALKALINE PHOSPHATASE; GLYCOSAMINOGLYCAN; LOW MOLECULAR WEIGHT HEPARIN; PARNAPARIN;

ANALYZER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; COMPUTER PROGRAM; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART; HISTOLOGY; IMAGE ANALYSIS; KIDNEY; MALE; MEASUREMENT; MORPHOLOGY; NONHUMAN; ORGAN INJURY; PARAMETER; PERIODIC ACID SCHIFF STAIN; PHOTOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; RETINA; VASCULAR DISEASE;

ANIMALS; ANTICOAGULANTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; HEART; HEPARIN, LOW-MOLECULAR-WEIGHT; KIDNEY; MALE; MYOCARDIUM; RATS; RATS, WISTAR;

EID: 2142755811     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00250-7     Document Type: Article

References (25)

1. Abbott R.D., Donohue R.P., Kannel W.B., Wilson P.W. The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham study. Journal of the American Medical Association. 260:1988;3456-3460
2. Anguilar O.M., Kleiman N.S. Low molecular weight heparins. Expert Opinion on Pharmacotherapy. 1:2000;1091-1103
3. Artico M., Massa R., Cavallotti D., Franchitto S., Cavallotti C. Morphological changes in the sciatic nerve of diabetic rats treated with low molecular weight heparin OP 2123/parnaparin. Anatomia, Histologia, Embryologia. 34:2002;1-5
4. Borch-Johnsen K., Norgaard K., Hommel E., Mathiesen E.R., Jensen J.S., Deckert T., Parving H.H. Is diabetic nephropathy an inherited complication? Kidney International. 41:1991;719-722
5. Burck H.C. Histologische technik. 1954;136 Thieme, Stuttgart
6. Burstone M.S. Histochemical demonstration of phosphatases in frozen sections with naphthol AS-phosphates. Journal of Histochemistry and Cytochemistry. 9:1961;146-153
7. Castino M., Roletto E. Statistica Applicata. 1992;Piccin, Padua
8. Cooper M.E. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet. 352:1998;213-219
9. DCCT Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 329:1993;1456-1462
10. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 32:1989;219-226
11. Dix D., Andrew M., Marzinotto V., Charpentier K., Bridge S., Monagle P., de Veber G., Leaker M., Chan A.K., Massicotte M.P. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. Journal of Pediatrics. 136:2000;439-445
12. Feldman E.L., Stevens M.J., Greene D.A. Pathogenesis of diabetic neuropathy. Clinical Neuroscience. 4:1997;365-370
13. Gomori G. Microscopic histochemistry. 1952;University of Chicago Press, Chicago
14. Haffner S.M., Lehto S., Ronnemaa T., Pyorälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England Journal of Medicine. 339:1998;224-229
15. Hehenberger K., Kratz G., Hansson A., Brismar K. Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. Journal of Dermatological Science. 16:1998;144-151
16. Hirsh J. LMWH. A review of the results of recent studies on the treatment of venous thromboembolism and unstable angina. Circulation. 98:1998;1575-1582
17. Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. New England Journal of Medicine. 329:1993;1456-1462
18. Manual of Methods of Quantiment Leica 500 microsystems imaging solutions. 1997;Clifton Road, Cambridge
19. McMillan D.E. Diabetic angiopathy. Its lessons in vascular physiology. American Heart Journal. 96:1978;401-406
20. Mogensen C.E. How to protect the kidney in diabetic patients. Diabetes. 46:1997;104-111
21. Oi K., Komori H., Kajinuma H. Changes in plasma glucose, insulin, glucagons, catecholamine and glycogen contents in tissues during development of alloxan diabetes mellitus in rats. Biochemical and Molecular Medicine. 62:1997;70-75
22. Serio, A. (1986). Appunti dalle lezioni di Statistica Sanitaria, Kappa, Rome.
23. Stoward P.J., Pearse A.G.E. Histochemistry, 4th ed. vol. 3:1991;Churchill Livingstone, Edinburgh
24. van der Woude F.J. Heparins in diabetic microangiopathy: rationale and preliminary clinical results. Haemostasis. 29:1999;61-67. suppl.
25. Vanpee D., Gillet J.B., Swine C. Low molecular weight heparin. Annals of Emergency Medicine. 36:2000;277-278